- Alternative Medicine
- Mesothelioma Cure
- Mesothelioma Research
- Mesothelioma Doctors
- Mesothelioma Cancer Centers
- Mesothelioma Clinical Trials
Over 30 Billion dollars in trust fund money has been set aside for asbestos victims.
Get a Free copy of Surviving Mesothelioma, Lean on Me, or 100 Questions & Answers About Mesothelioma
Mesolink.org now offeres Free Assistance with VA Claims and other benefits.
Dr. Scott N Gettinger
Contact Information
- One Healthy Way, Oceanside, NY 11572
- (516) 255-5010
- scott.gettinger@yale.edu
Dr. Scott N. Gettinger serves patients in New Haven, Connecticut at the Yale University Cancer Center. He has a second practice in New Haven, as well. Dr. Gettinger, who practices oncology and internal medicine, specializes in treating patients with mesothelioma. Mesothelioma is a rare cancer that is caused by asbestos inhalation, and which generally has a grim prognosis—most patients die within months of learning they have this type of cancer.
Dr. Gettinger focuses on clinical trial design; early detection devices such as prognostic biomarkers; leading edge cancer therapy treatments; and radiosensitizers. Radiosensitizers are devices that accelerate or make the tumor more susceptible to radiation therapy. His goal is to alleviate side effects associated with some cancer therapies, as well as, discover more effective treatments. Dr. Gettinger also specializes in chest wall tumors, thyroid cancer, head and neck cancer, thymoma, and other lung cancers.
In 1999, he graduated with an M.D. from the State University of New York at Brooklyn. After medical school, he completed his residency in 2002, as well as his fellowship in 2005, at the Beth Israel Medical Center in Manhattan. His residency was in internal medicine and his fellowship in medical oncology and hematology. While completing his fellowship at the Beth Israel Medical Center, he focused his efforts on the head and neck oncology research and clinical trial design.
Dr. Gettinger currently serves on the faculty at Yale University School of Medicine, as an assistant professor of medical oncology, and was selected for a position at the Yale University Cancer Center in 2005. The Director of Yale Cancer Center selected him primarily because of his innovative approach to finding treatments for head and neck cancers. While serving as a part of the clinical research faculty at Yale University Cancer Center, Dr. Gettinger also accepted a position with the Yale-New Haven Thoracic Oncology Program. As a part of this team, he assisted in the design of novel clinical trials and the development of innovative treatments for patients afflicted with lung cancer.
Dr. Gettinger is board-certified in internal medicine (2002) and in medical oncology (2005). He is one of the leading mesothelioma oncologists in Connecticut, and as such is committed to providing quality care to ease patients' symptoms, extend their lives and improve the quality of their lives.